|
|
|
| home > news |
|
|
 INDUSTRY NEWS AND PRESS RELEASES |
|
|
Bioclinica Introduces Oncology Rescue Studies Team
Dedicated specialists focus on at-risk trials, driving toward new Oncology therapies
More>> |
|
|
Bioclinica Launches Clean Patient Optics to Accelerate Database Lock and Clinical Trial Timelines
Empowers sponsors and CROs with insights on study health
More>> |
|
|
Elsevier launches solution to accelerate drug discovery through comprehensive prediction and assessment of drug-drug interactions
New PharmaPendium solution comes with DDI risk calculator enabling earlier and more complete risk mitigation strategies for potential drug-drug interactions
More>> |
|
|
Natoli Engineering Company Announces Metal Detectable Dust Cups and Bellows
Natoli Engineering Company, Inc announces an addition to their Tablet Compression Accessories Catalog—metal detectable dust cups and bellows.
More>> |
|
|
Aptar Pharma Extends its Child-Resistant Nasal Pump Manufacturing Capabilities in North America
Aptar Pharma announces the installation of manufacturing capacity for its Child-Resistant and Senior-Friendly Classic Nasal Pump in their Congers, NY site
More>> |
|
|
Chiltern Acquires Japanese Clinical Research Organization Integrated Development Associates Co. Ltd.
Chiltern, a leading global contract research organization, has acquired Integrated Development Associates Co. Ltd. (IDA), a CRO specializing in integrating Japan and Asia into global drug development.
More>> |
|
|
UK:+44(0)1753 512 000; US:+1 (423) 968 9533
|
|
info@chiltern.com
|
|
www.chiltern.com
|
|
UK: 171 Bath Road, Slough, Berkshire, SL1 4AA. US: 3147 S. 17th Street, Suite 300 Wilmington, NC 28412.
|
| |
|
PRISYM ID to Exhibit at the Clinical Trials Supply Nordics Event
PRISYM ID, leading provider of labelling solutions for the life sciences industries, is exhibiting at The Clinical Trial Supply Event in Copenhagen, Denmark on the 7/8th June 2017, on stand 6
More>> |
|
|
Wickham Laboratories Announces Upcoming Webinar on In-Vitro Alternatives
Join us for a free webinar to discuss the challenges of transitioning from in-vivo to in-vitro methods
More>> |
|
|
Quanterix Launches the First Comprehensive Multiplex Panel to Study Traumatic Brain Injury Severity
New panel offers unmatched sensitivity to simultaneously measure four proven neurological protein biomarkers in blood and cerebrospinal fluid within a single test
More>> |
|
|
Owlstone Medicals ReCIVA Named Invention of the Year in Top 50 Digital Health Awards
Awards recognize exceptional progress in bringing technological advancements to healthcare
More>> |
|
|
|
+44 (0)1223 428200
|
|
|
www.owlstonenanotech.com
|
|
|
Owlstone Ltd, 127 Cambridge Science Park, Milton Road, Cambridge, CB4 0GD, UK
|
| |
|
|
 |
|
|
 |
News and Press Releases |
 |
Klöckner Pentaplast to introduce latest shrink label technologies and delivery master class at Labelexpo Americas 2016
More info >> |
|
 |
White Papers |
 |
|
Maximize the ROI of Your Post-Approval Research
Bioclinica
Expenditures in post-approval (Phase IV) research are going up across the pharmaceutical, biotech and medical device industries. Given the resources you’ve committed to post-approval research, you may be wondering if you’re getting the greatest possible return on your investment.
Discover how to harness the power of post-approval research to increase data collection, reduce resource burn, save money, and maximize your ROI!
More info >> |
|
 |
Industry Events |
 |
Outsourcing in Clinical Trials Nordics 2017
10-11 October 2017, Copenhagen, Denmark
Enabling local
knowledge-sharing, benchmarking and network-building between Nordic biopharma
and device industry peers
More info >> |
|
|
